Eton Pharmaceuticals, Inc. (ETON)
17.23
-0.30
(-1.71%)
USD |
NASDAQ |
Mar 05, 16:00
17.23
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Cash from Investing (Quarterly) : -0.284M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -11.84M |
| Johnson & Johnson | -4.485B |
| Vir Biotechnology, Inc. | 86.65M |
| Sensei Biotherapeutics, Inc. | 8.757M |
| Picard Medical, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 12.03M |
| Free Cash Flow | 12.89M |
| Free Cash Flow Per Share (Quarterly) | 0.4366 |
| Free Cash Flow to Equity (Quarterly) | 11.56M |
| Free Cash Flow to Firm (Quarterly) | 12.94M |
| Free Cash Flow Yield | 2.80% |